Hammam Farouk Alquadan, MBBS

Hammam Alquadan practices at Hmhmg Specialty Care in Hackensack, New Jersey.

Hammam Alquadan's NPI, 1366887549, was assigned on May 1, 2013. Hammam Alquadan holds Arizona license 48748.

Hammam Alquadan's primary practice is Hmhmg Specialty Care, at 360 Essex St, Hackensack, NJ 07601 in Bergen County. The practice phone is (732) 807-0800.

Hammam Alquadan's primary practice is Hmhmg Specialty Care in Hackensack, New Jersey. Hammam Alquadan is also affiliated with Atlantic Health CentraState Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Hammam Alquadan to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Hammam Alquadan practices, 7 sites in all. Vendor and product names are available with a free account.

Internal medicine is Hammam Alquadan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Hammam Alquadan is licensed in Arizona.

CMS data shows 1,573 Medicare services from Hammam Alquadan across 9 procedure codes in 2024, for 255 Medicare patients. Medicare paid $89,629 for them.

CMS counts 255 Medicare patients who saw Hammam Alquadan in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Hammam Alquadan's median patient age at 58, with 64% women.

In 2024, Hammam Alquadan wrote 1,774 Medicare Part D claims for 333 patients. 39% of them were for generic drugs. CMS names the drug for 1,470 of them, across 32 drugs with 11 or more claims each, at $823,620 in total drug cost. In 2023, CMS named 666 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Hammam Alquadan for performance year 2024, reported as part of a group. Hammam Alquadan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Hammam Alquadan as offering telehealth.

CMS Open Payments shows 183 general payments to Hammam Alquadan from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Novo Nordisk Inc paid the most, $393.